Virtu KCG Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-4,400
Closed -$614K 3019
2015
Q4
$614K Buy
+4,400
New +$606K 0.01% 1317
2015
Q3
Sell
-1,600
Closed -$263K 3452
2015
Q2
$263K Buy
+1,600
New +$256K ﹤0.01% 2240
2015
Q1
Sell
-9,600
Closed -$1.21M 3324
2014
Q4
$1.21M Buy
9,600
+6,700
+231% +$828K 0.02% 774
2014
Q3
$347K Sell
2,900
-9,700
-77% -$1.11M 0.01% 2142
2014
Q2
$1.36M Sell
12,600
-33,800
-73% -$3.48M 0.02% 875
2014
Q1
$4.62M Buy
46,400
+34,400
+287% +$3.11M 0.06% 287
2013
Q4
$1.11M Sell
12,000
-17,700
-60% -$1.57M 0.01% 1124
2013
Q3
$2.48M Buy
+29,700
New +$2.55M 0.03% 497

Other funds holding ELV

Virtu KCG Holdings's ELV Position: Q2 2017 in Review

Virtu KCG Holdings increased its Elevance Health (ELV) stake by 29% in Q2 2017, buying an estimated $1.18M and bringing the position to 28,959 shares worth $5.45M. The position accounts for 0.15% of the portfolio, ranked #55.

Virtu KCG Holdings first reported a position in ELV in Q3 2013 and has held it in 16 quarters since. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • Virtu KCG Holdings held 28,959 shares of Elevance Health worth $5.45M as of Q2 2017.
  • Virtu KCG Holdings bought 6,542 Elevance Health shares in Q2 2017, an estimated $1.18M.
  • Elevance Health made up 0.15% of Virtu KCG Holdings's portfolio in Q2 2017, its #55 holding.
  • Virtu KCG Holdings first reported a position in Elevance Health in Q3 2013 and has held it in 16 quarters since.
  • 851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.